|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 30/06 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Comp Growth Benchmark | CI |
| 30/06 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 72Cr 63Cr 59Cr 54Cr 100.76Cr 6.85TCr 103.24Cr 695.49Cr 271.99Cr 3.39TCr 268.48Cr 262.65Cr 12TCr | P/E 2026 * |
-7.89x | P/E 2027 * | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 58Cr 51Cr 48Cr 44Cr 82Cr 5.55TCr 84Cr 563.6Cr 220.41Cr 2.75TCr 217.57Cr 212.84Cr 9.49TCr | EV / Sales 2026 * |
101x | EV / Sales 2027 * | 110x |
| Free-Float |
97.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACLS THER
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 17/01/2024 |
Hugh Davis
PSD | President | 67 | 18/11/2024 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 01/01/2023 |
Anand Mehra
BRD | Director/Board Member | 50 | 01/09/2014 |
| Director/Board Member | 59 | 01/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.84% | -5.50% | +43.96% | +64.81% | 5.52TCr | |
| +2.83% | +0.48% | +28.18% | +82.59% | 5.56TCr | |
| +0.54% | +1.22% | -16.62% | -13.47% | 2.35TCr | |
| -0.97% | -3.30% | -1.79% | +383.00% | 2.24TCr | |
| -4.01% | -3.67% | +13.17% | -14.29% | 2.06TCr | |
| -1.74% | -3.62% | +25.38% | -34.16% | 1.74TCr | |
| -3.34% | -7.77% | +23.78% | +536.66% | 1.52TCr | |
| -2.09% | +0.64% | +49.78% | +178.74% | 1.39TCr | |
| -3.14% | -8.47% | +165.37% | +292.18% | 1.37TCr | |
| Average | -1.65% | -1.27% | +36.80% | +164.01% | 2.64TCr | |
| Weighted average by Cap. | -1.04% | -0.52% | +32.01% | +126.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.13L 50.2L 46.85L 43L 80.49L 55Cr 82.48L 5.56Cr 2.17Cr 27Cr 2.14Cr 2.1Cr 94Cr | 53.58L 47.08L 43.95L 40.33L 75.5L 51Cr 77.36L 5.21Cr 2.04Cr 25Cr 2.01Cr 1.97Cr 88Cr |
| Net income | -8.48Cr -7.45Cr -6.95Cr -6.38Cr -12Cr -812.08Cr -12Cr -82Cr -32Cr -401.85Cr -32Cr -31Cr -1.39TCr | -10Cr -9.01Cr -8.41Cr -7.72Cr -14Cr -981.91Cr -15Cr -100Cr -39Cr -485.89Cr -38Cr -38Cr -1.68TCr |
| Net Debt | -14Cr -12Cr -11Cr -10Cr -19Cr -1.3TCr -20Cr -131.88Cr -52Cr -642.71Cr -51Cr -50Cr -2.22TCr | -12Cr -11Cr -10Cr -9.4Cr -18Cr -1.2TCr -18Cr -121.48Cr -48Cr -592Cr -47Cr -46Cr -2.05TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
